| Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ... JAMA oncology 3 (12), 1663-1672, 2017 | 263 | 2017 |
| The DNA methylation landscape of advanced prostate cancer SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ... Nature genetics 52 (8), 778-789, 2020 | 231 | 2020 |
| Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ... The lancet oncology 17 (11), 1612-1620, 2016 | 212 | 2016 |
| Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome S You, BS Knudsen, N Erho, M Alshalalfa, M Takhar, H Al-deen Ashab, ... Cancer research 76 (17), 4948-4958, 2016 | 176 | 2016 |
| Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes SA Tomlins, M Alshalalfa, E Davicioni, N Erho, K Yousefi, S Zhao, ... European urology 68 (4), 555-567, 2015 | 153 | 2015 |
| Efficient periodicity mining in time series databases using suffix trees F Rasheed, M Alshalalfa, R Alhajj IEEE Transactions on Knowledge and Data Engineering 23 (1), 79-94, 2010 | 153 | 2010 |
| High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program DP Labbé, G Zadra, M Yang, JM Reyes, CY Lin, S Cacciatore, EM Ebot, ... Nature communications 10 (1), 4358, 2019 | 140 | 2019 |
| Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis B Benzon, SG Zhao, MC Haffner, M Takhar, N Erho, K Yousefi, P Hurley, ... Prostate cancer and prostatic diseases 20 (1), 28-35, 2017 | 138 | 2017 |
| Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer L Yang, D Roberts, M Takhar, N Erho, BAS Bibby, N Thiruthaneeswaran, ... EBioMedicine 31, 182-189, 2018 | 137 | 2018 |
| Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer A Urbanucci, SJ Barfeld, V Kytölä, HM Itkonen, IM Coleman, D Vodák, ... Cell reports 19 (10), 2045-2059, 2017 | 124 | 2017 |
| The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer JR Prensner, A Sahu, MK Iyer, R Malik, B Chandler, IA Asangani, ... Oncotarget 5 (6), 1434, 2014 | 117 | 2014 |
| Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies R Stoyanova, A Pollack, M Takhar, C Lynne, N Parra, LLC Lam, ... Oncotarget 7 (33), 53362, 2016 | 113 | 2016 |
| TOP2A and EZH2 provide early detection of an aggressive prostate cancer subgroup DP Labbé, CJ Sweeney, M Brown, P Galbo, S Rosario, KM Wadosky, ... Clinical Cancer Research 23 (22), 7072-7083, 2017 | 111 | 2017 |
| Racial differences in genomic profiling of prostate cancer BA Mahal, M Alshalalfa, KH Kensler, I Chowdhury-Paulino, P Kantoff, ... New England Journal of Medicine 383 (11), 1083-1085, 2020 | 97 | 2020 |
| Clinical and genomic characterization of low–prostate-specific antigen, high-grade prostate cancer BA Mahal, DD Yang, NQ Wang, M Alshalalfa, E Davicioni, V Choeurng, ... European urology 74 (2), 146-154, 2018 | 96 | 2018 |
| Racial variations in prostate cancer molecular subtypes and androgen receptor signaling reflect anatomic tumor location FA Faisal, D Sundi, JJ Tosoian, V Choeurng, M Alshalalfa, AE Ross, ... European urology 70 (1), 14-17, 2016 | 89 | 2016 |
| Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity J Cyrta, A Augspach, MR De Filippo, D Prandi, P Thienger, M Benelli, ... Nature communications 11 (1), 5549, 2020 | 87 | 2020 |
| Molecular characterization of neuroendocrine-like bladder cancer J Batista da Costa, EA Gibb, TJ Bivalacqua, Y Liu, HZ Oo, DT Miyamoto, ... Clinical cancer research 25 (13), 3908-3920, 2019 | 84 | 2019 |
| Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer DE Spratt, M Alshalalfa, N Fishbane, AB Weiner, R Mehra, BA Mahal, ... Clinical Cancer Research 25 (22), 6721-6730, 2019 | 83 | 2019 |
| The diverse genomic landscape of clinically low-risk prostate cancer MR Cooperberg, N Erho, JM Chan, FY Feng, N Fishbane, SG Zhao, ... European urology 74 (4), 444-452, 2018 | 78 | 2018 |
